ClinicalTrials.Veeva

Menu

Probiotics Regulate Intestinal Health and Alleviate Anxiety

W

Wecare Probiotics

Status

Completed

Conditions

Anxiety Depression

Treatments

Dietary Supplement: probiotics group
Dietary Supplement: Placebo Group

Study type

Interventional

Funder types

Industry

Identifiers

NCT07353320
WK20251224

Details and patient eligibility

About

This study is a randomized, double-blind, placebo-controlled trial aimed primarily at investigating the effects of Weizmannia coagulans BC99 on alleviating anxiety and depression and the gut microbiota.

Enrollment

79 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Adults aged 18-65 years.
  2. Individuals experiencing scientific research, employment-related, or occupational stress, including graduate students or community-dwelling adults with job-related pressure.
  3. A Hamilton Depression Rating Scale (HAMD-17) score ≥ 8 and/or a Hamilton 4) Anxiety Rating Scale (HAMA-14) score ≥ 7 at screening.

5)Ability and willingness to voluntarily participate in the study and to provide written informed consent prior to enrollment.

Exclusion criteria

  1. A confirmed previous diagnosis of other psychiatric disorders, including intellectual disability, bipolar disorder, treatment-resistant depression, or suicidal ideation.
  2. Pregnant or breastfeeding women.
  3. Individuals with known food or drug allergies, or those with alcohol abuse or psychotropic substance abuse.
  4. Use of antibiotics or probiotics known to affect gut microbiota for more than one week within one month prior to enrollment.
  5. Participants who withdrew from the study, discontinued intervention, or were unable to complete the study for any reason.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

79 participants in 2 patient groups, including a placebo group

Experimental : probiotics group
Experimental group
Description:
5 billion CFU/day BC99 and protein powder; Storage: sealed, protected from light, placed in a cool and dry place.
Treatment:
Dietary Supplement: probiotics group
Placebo Comparator : placebo group
Placebo Comparator group
Description:
Dextrin powder, 1 bags per day; Storage: sealed, protected from light, placed in a cool and dry place.
Treatment:
Dietary Supplement: Placebo Group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems